Please wait a minute...
J Zhejiang Univ (Med Sci)  2019, Vol. 48 Issue (3): 233-240    DOI: 10.3785/j.issn.1008-9292.2019.06.01
    
Advances in surgical treatment of ischemic cerebrovascular disease
ZHANG Jianmin()
Department of Neurosurgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China
Download: HTML( 37 )   PDF(0KB)
Export: BibTeX | EndNote (RIS)      

Abstract  

Restoration of cerebral blood flow is particularly important for the treatment of ischemic cerebrovascular disease. It is notable that surgical approaches play a unique role in treating this devastating disease. Among them, mechanical thrombectomy facilitates rapid and effective recanalization of occluded intracranial large vessels causing ischemic stroke, which contributes to improvement of cerebral perfusion in the ischemic penumbra; decompressive craniectomy is an important therapeutic option for acute massive cerebral infarction, and the timing of surgery determines the final clinical outcomes; for carotid endarterectomy in carotid-artery stenosis, individualized surgical plan is important for the safety and effectiveness of the operation; in the surgical revascularization of Moyamoya disease, precise evaluation of clinical and radiological characteristics, optimal surgical strategies and accuracy of intraoperative judgment will yield maximal therapeutic effects; and hybrid surgery is feasible for the therapy of complex ischemic cerebrovascular diseases, such as extracranial/intracranial arteries tandem stenosis and symptomatic chronic total occlusion of carotid artery. This paper reviews recent technical and clinical advances in the surgical treatment of ischemic cerebrovascular disease.



Key wordsBrain ischemia/therapy      Surgical procedures, operative/methods      Endarterectomy, carotid      Stroke      Combined modality therapy      Review     
Received: 01 June 2019      Published: 04 September 2019
CLC:  R743  
Cite this article:

ZHANG Jianmin. Advances in surgical treatment of ischemic cerebrovascular disease. J Zhejiang Univ (Med Sci), 2019, 48(3): 233-240.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2019.06.01     OR     http://www.zjujournals.com/med/Y2019/V48/I3/233


缺血性脑血管疾病手术治疗新进展

恢复脑组织血流供应是缺血性脑血管疾病治疗的关键。手术治疗在缺血性脑血管疾病的治疗中有着重要作用。机械取栓术能使急性闭塞的颅内大血管迅速而有效地开通,最大可能挽救低灌注区域缺血脑组织的血供;去骨瓣减压术作为治疗大面积脑梗死的常规备选方案,手术时机的选择是决定疗效的重要因素;颈动脉内膜切除术作为预防缺血性脑卒中的重要手段,个体化手术方案的选择有助于提高手术的疗效和安全性;对于烟雾病实施脑血流重建术,精准的临床和影像学评估、合理的手术方案制订和准确的术中判断是保证手术效果的关键;复合手术适合处理颅内/外血管长节段狭窄和(或)慢性闭塞等复杂性缺血性脑血管疾病。本文围绕上述常见的缺血性脑血管疾病的手术治疗及临床应用新进展进行阐述。


关键词: 脑缺血/治疗,  外科手术/方法,  颈动脉内膜切除术,  卒中,  综合疗法,  综述 
[1]   HACKE W , KASTE M , BLUHMKI E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med, 2008, 359 (13): 1317- 1329
doi: 10.1056/NEJMoa0804656
[2]   ALEXANDROV A V , GROTTA J C . Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator[J]. Neurology, 2002, 59 (6): 862- 867
doi: 10.1212/WNL.59.6.862
[3]   ALEXANDROV A V . Current and future recanalization strategies for acute ischemic stroke[J]. J Intern Med, 2010, 267 (2): 209- 219
doi: 10.1111/j.1365-2796.2009.02206.x
[4]   SMITH W S , LEV M H , ENGLISH J D et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA[J]. Stroke, 2009, 40 (12): 3834- 3840
doi: 10.1161/STROKEAHA.109.561787
[5]   GOYAL M , MENON B K , VAN ZWAM W H et al. Endovascular thrombectomy after large-vessel ischaemic stroke:a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016, 387 (10029): 1723- 1731
doi: 10.1016/S0140-6736(16)00163-X
[6]   ALBERS G W , MARKS M P , KEMP S et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med, 2018, 378 (8): 708- 718
doi: 10.1056/NEJMoa1713973
[7]   NOGUEIRA R G , JADHAV A P , HAUSSEN D C et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med, 2018, 378 (1): 11- 21
doi: 10.1056/NEJMoa1706442
[8]   MCTAGGART R A , ANSARI S A , GOYAL M et al. Initial hospital management of patients with emergent large vessel occlusion (ELVO):report of the standards and guidelines committee of the Society of NeuroInterventional Surgery[J]. J Neurointerv Surg, 2017, 9 (3): 316- 323
doi: 10.1136/neurintsurg-2015-011984
[9]   BOURCIER R , GOYAL M , LIEBESKIND D S et al. Association of time from stroke onset to groin puncture with quality of reperfusion after mechanical thrombectomy:a meta-analysis of individual patient data from 7 randomized clinical trials[J]. JAMA Neurol, 2019, 76 (4): 405- 411
doi: 10.1001/jamaneurol.2018.4510
[10]   TURK A S 3RD , SIDDIQUI A , FIFI J T et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS):a multicentre, randomised, open label, blinded outcome, non-inferiority trial[J]. Lancet, 2019, 393 (10175): 998- 1008
doi: 10.1016/S0140-6736(19)30297-1
[11]   TEXAKALIDIS P , GIANNOPOULOS S , KARASAVVIDIS T et al. Mechanical thrombectomy in acute ischemic stroke:a meta-analysis of stent retrievers vs direct aspiration vs a combined approach[J]. Neurosurgery, 2019, pii:nyz258
[12]   BRACARD S , DUCROCQ X , MAS J L et al. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE):a randomised controlled trial[J]. Lancet Neurol, 2016, 15 (11): 1138- 1147
doi: 10.1016/S1474-4422(16)30177-6
[13]   COUTINHO J M , LIEBESKIND D S , SLATER L A et al. Combined intravenous thrombolysis and thrombectomy vs thrombectomy alone for acute ischemic stroke:a pooled analysis of the SWIFT and STAR studies[J]. JAMA Neurol, 2017, 74 (3): 268- 274
doi: 10.1001/jamaneurol.2016.5374
[14]   KAYAN Y , MEYERS P M , PRESTIGIACOMO C J et al. Current endovascular strategies for posterior circulation large vessel occlusion stroke:report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee[J]. J Neurointerv Surg, 2019,
[15]   WOLLENWEBER F A , TIEDT S , ALEGIANI A et al. Functional outcome following stroke thrombectomy in clinical practice[J]. Stroke, 2019, STROKEAHA119026005
[16]   ROMáN L S , MENON B K , BLASCO J et al. Imaging features and safety and efficacy of endovascular stroke treatment:a meta-analysis of individual patient-level data[J]. Lancet Neurol, 2018, 17 (10): 895- 904
doi: 10.1016/S1474-4422(18)30242-4
[17]   BEEZ T , MUNOZ-BENDIX C , STEIGER H J et al. Decompressive craniectomy for acute ischemic stroke[J]. Crit Care, 2019, 23 (1): 209
doi: 10.1186/s13054-019-2490-x
[18]   SLOTTY P J , KAMP M A , BEEZ T et al. The influence of decompressive craniectomy for major stroke on early cerebral perfusion[J]. J Neurosurg, 2015, 123 (1): 59- 64
doi: 10.3171/2014.12.JNS141250
[19]   QURESHI A I , SUAREZ J I , YAHIA A M et al. Timing of neurologic deterioration in massive middle cerebral artery infarction:a multicenter review[J]. Crit Care Med, 2003, 31 (1): 272- 277
[20]   VAHEDI K , VICAUT E , MATEO J et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial)[J]. Stroke, 2007, 38 (9): 2506- 2517
doi: 10.1161/STROKEAHA.107.485235
[21]   PALLESEN L P , BARLINN K , PUETZ V . Role of decompressive craniectomy in ischemic stroke[J]. Front Neurol, 2018, 9:1119
[22]   VAHEDI K , HOFMEIJER J , JUETTLER E et al. Early decompressive surgery in malignant infarction of the middle cerebral artery:a pooled analysis of three randomised controlled trials[J]. Lancet Neurol, 2007, 6 (3): 215- 222
doi: 10.1016/S1474-4422(07)70036-4
[23]   HOFMEIJER J , KAPPELLE L J , ALGRA A et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial[HAMLET]):a multicentre, open, randomised trial[J]. Lancet Neurol, 2009, 8 (4): 326- 333
doi: 10.1016/S1474-4422(09)70047-X
[24]   CHO D Y , CHEN T C , LEE H C . Ultra-early decompressive craniectomy for malignant middle cerebral artery infarction[J]. Surg Neurol, 2003, 60 (3): 227- 233
doi: 10.1016/S0090-3019(03)00266-0
[25]   BEEZ T , STEIGER H J . Impact of randomized controlled trials on neurosurgical practice in decompressive craniectomy for ischemic stroke[J]. Neurosurg Rev, 2019, 42 (1): 133- 137
doi: 10.1007/s10143-018-0967-8
[26]   DEBAKEY M E . Successful carotid endarterectomy for cerebrovascular insufficiency. Nineteen-year follow-up[J]. JAMA, 1975, 233 (10): 1083- 1085
doi: 10.1001/jama.1975.03260100053020
[27]   North American Symptomatic Carotid Endarterectomy Trial Collaborators , BARNETT H , TAYLOR D W et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis[J]. N Engl J Med, 1991, 325 (7): 445- 453
doi: 10.1056/NEJM199108153250701
[28]   BARNETT H J , TAYLOR D W , ELIASZIW M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators[J]. N Engl J Med, 1998, 339 (20): 1415- 1425
doi: 10.1056/NEJM199811123392002
[29]   HALLIDAY A , MANSFIELD A , MARRO J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms:randomised controlled trial[J]. Lancet, 2004, 363 (9420): 1491- 1502
doi: 10.1016/S0140-6736(04)16146-1
[30]   Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)[J]. Lancet, 1998, 351(9113): 1379-1387.
[31]   YADAV J S , WHOLEY M H , KUNTZ R E et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients[J]. N Engl J Med, 2004, 351 (15): 1493- 1501
doi: 10.1056/NEJMoa040127
[32]   BROTT T G , HOWARD G , ROUBIN G S et al. Long-term results of stenting versus endarterectomy for carotid-artery stenosis[J]. N Engl J Med, 2016, 374 (11): 1021- 1031
doi: 10.1056/NEJMoa1505215
[33]   BONATI L H , DOBSON J , FEATHERSTONE R L et al. Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis:the International Carotid Stenting Study (ICSS) randomised trial[J]. Lancet, 2015, 385 (9967): 529- 538
doi: 10.1016/S0140-6736(14)61184-3
[34]   HUIZING E , VOS C G , VAN DEN AKKER P J et al. A systematic review of patch angioplasty versus primary closure for carotid endarterectomy[J]. J Vasc Surg, 2019, 69 (6): 1962- 1974
doi: 10.1016/j.jvs.2018.10.096
[35]   PARASKEVAS K I , ROBERTSON V , SARATZIS A N et al. Editor's choice-an updated systematic review and meta-analysis of outcomes following eversion vs. conventional carotid endarterectomy in randomised controlled trials and observational studies[J]. Eur J Vasc Endovasc Surg, 2018, 55 (4): 465- 473
doi: 10.1016/j.ejvs.2017.12.025
[36]   BENNETT K M , SCARBOROUGH J E , COX M W et al. The impact of intraoperative shunting on early neurologic outcomes after carotid endarterectomy[J]. J Vasc Surg, 2015, 61 (1): 96- 102
[37]   WOODWORTH G F , MCGIRT M J , THAN K D et al. Selective versus routine intraoperative shunting during carotid endarterectomy:a multivariate outcome analysis[J]. Neurosurgery, 2007, 61 (6): 1170- 1177
[38]   CHONGRUKSUT W , VANIYAPONG T , RERKASEM K . Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting)[J]. Cochrane Database Syst Rev, 2014, (6): CD000190
[39]   SUZUKI J , TAKAKU A . Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain[J]. Arch Neurol, 1969, 20 (3): 288- 299
doi: 10.1001/archneur.1969.00480090076012
[40]   JANG D K , LEE K S , RHA H K et al. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults[J]. J Neurosurg, 2017, 127 (3): 492- 502
doi: 10.3171/2016.8.JNS152875
[41]   DENG X , GE P , WANG S et al. Treatment of moyamoya disease[J]. Neurosurgery, 2018, 65 (CN_suppl_1): 62- 65
doi: 10.1093/neuros/nyy114
[42]   ARIAS E J , DERDEYN C P , DACEY R G JR et al. Advances and surgical considerations in the treatment of moyamoya disease[J]. Neurosurgery, 2014, 74 (Suppl 1): S116- S125
[43]   MIYAMOTO S , YOSHIMOTO T , HASHIMOTO N et al. Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease:results of the Japan Adult Moyamoya Trial[J]. Stroke, 2014, 45 (5): 1415- 1421
doi: 10.1161/STROKEAHA.113.004386
[44]   UCHINO H , KASHIWAZAKI D , AKIOKA N et al. Strategy and effect of repeat bypass surgery for anterior/posterior circulation in refractory moyamoya disease[J]. J Neurosurg, 2019, 1- 11
[45]   SMITH E R , SCOTT R M . Spontaneous occlusion of the circle of Willis in children:pediatric moyamoya summary with proposed evidence-based practice guidelines. A review[J]. J Neurosurg Pediatr, 2012, 9 (4): 353- 360
doi: 10.3171/2011.12.PEDS1172
[46]   RIORDAN C P , STOREY A , COTE D J et al. Results of more than 20 years of follow-up in pediatric patients with moyamoya disease undergoing pial synangiosis[J]. J Neurosurg Pediatr, 2019, 1- 7
[47]   SHIH Y T , CHEN W H , LEE W L et al. Hybrid surgery for symptomatic chronic total occlusion of carotid artery:a technical note[J]. Neurosurgery, 2013, 73 (1 Suppl Operative): onsE117- onsE123
[48]   LIU B, WEI W, WANG Y, et al. Estimation and recanalization of chronic occluded internal carotid artery: hybrid operation by carotid endarterectomy and endovascular angioplasty[J/OL]. World Neurosurg, 2018, 120: e457-e465.
[49]   HASAN D , ZANATY M , STARKE R M et al. Feasibility, safety, and changes in systolic blood pressure associated with endovascular revascularization of symptomatic and chronically occluded cervical internal carotid artery using a newly suggested radiographic classification of chronically occluded cervical internal carotid artery:pilot study[J]. J Neurosurg, 2018, 1- 10
[50]   MEERSHOEK A , VELDE H M , TOOROP R J et al. Long-term outcome of symptomatic patients undergoing hybrid revascularisation for extracranial carotid artery tandem stenosis[J]. Eur J Vasc Endovasc Surg, 2019, 57 (5): 627- 631
doi: 10.1016/j.ejvs.2018.11.016
[1] ZHANG Congcong, LOU Min, CHEN Zhicai, CHEN Hongfang, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Analysis of intravenous thrombolysis time and prognosis in patients with in-hospital stroke[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 260-266.
[2] ZHONG Wansi, CHEN Zhicai, CHEN Hongfang, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, LOU Min, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Effects of emergency medical service on prognosis of ischemic stroke patients treated with intravenous thrombolysis[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 241-246.
[3] TAO Anyang, WANG Zhimin, CHEN Hongfang, XU Dongjuan, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, LOU Min, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Association of atrial fibrillation with hemorrhagic transformation after intravenous thrombolysis in patients with ischemic stroke[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 254-259.
[4] ZHU Ziling, TAN Jing, DENG Hong. Nucleus translocation of membrane/cytoplasm proteins in tumor cells[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 318-325.
[5] CHEN Hongfang, GONG Xiaoxian, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, LOU Min, CHEN Zhicai, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Advanced treatment time improves outcomes of patients with ischemic stroke undergoing reperfusion therapy[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 247-253.
[6] PAN Feihu, LOU Min, CHEN Zhicai, CHEN Hongfang, XU Dongjuan, WANG Zhimin, HU Haifang, WU Chenglong, ZHANG Xiaoling, MA Xiaodong, WANG Yaxian, HU Haitao, Improving In-hospital Stroke Service Utilisation (MISSION) in Zhejiang Province . Effect of different working time on the prognosis of ischemic stroke patients undergoing intravenous thrombolysis[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 267-274.
[7] ZHANG Lisan, SUN Yi, WANG Tiantian, PAN Yu, YAO Ying, PAN Liuqing, XU Qinglin, ZHANG Wenying, XU Jiahui, HU Xingyue. Restless legs syndrome in ischemic stroke patients: clinical features and significance[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 275-281.
[8] WU Yuxing, ZHANG Shihong, CHEN Zhong. The roles of habenula and related neural circuits in neuropsychiatric diseases[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 310-317.
[9] ZHANG Yunzhu, ZHU Chunpeng, LU Xinliang. Advances in serum biomarkers for early diagnosis of gastric cancer[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 326-333.
[10] ZHANG Xinmei,XU Ping. Stratified treatment and management of adenomyosis[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 123-129.
[11] WU Binbin,YANG Yi. Biomarkers of cardiac surgery-associated acute kidney injury: a narrative review[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 224-229.
[12] YANG Kun,HU Xiaosheng. Research progress on miR-21 in heart diseases[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 214-218.
[13] XU Li,XU Ming,TONG Xiangmin. Effects of aerobic glycolysis on pathogenesis and drug resistance of non-Hodgkin lymphoma[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 219-223.
[14] Baboo Kalianee Devi,CHEN Zhengyun,ZHANG Xinmei. Progress on medical treatment in the management of adenomyosis[J]. J Zhejiang Univ (Med Sci), 2019, 48(2): 142-147.
[15] SONG Fangjun,GUO Hongtao. Progress on structural biology of voltage-gated ion channels[J]. J Zhejiang Univ (Med Sci), 2019, 48(1): 25-33.